glp-1 after pregnancy medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during or while nursing. The current recommendation is to stop before conception and discuss Discontinuing GLP-1s Before or Early

While semaglutide reduces LDL cholesterol by 5-10%, statins achieve much greater reductions of 30-50% and remain the cornerstone of lipid therapy according to ACC/AHA guidelines

Diarrhea occurs in approximately 30% of patients taking semaglutide 2.4 mg (Wegovy) and 19-23% of patients taking tirzepatide (Zepbound) according to FDA prescribing information

In the meantime, well continue to fight for patients every single day: helping ensure continuity of care for those already on GLP-1s and enabling new patients to start the most effective treatment available.

Notably, most studies were published very recently (20242025), highlighting the novelty of this topic and the emerging nature of GLP-1 research in this context